Hologic, Inc.HOLX
NasdaqGS•Healthcare•Medical Instruments & Supplies
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $4.13B, growing 2.2% year-over-year. TTM net income stood at $543.80M (26.9% contraction). Quarterly EBITDA was $306.60M and operating income was $237.00M. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze HOLX growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters